Theravance slips after setback for ampreloxetine in second Phase 3 hypotension trial
April 04 2022 - 4:27PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Theravance Biopharma (NASDAQ:TBPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Theravance Biopharma (NASDAQ:TBPH)
Historical Stock Chart
From Apr 2023 to Apr 2024